Daughton DM - Search Results

1

Efficacy of the nicotine inhaler in smoking reduction: A double-blind, randomized trial.

Rennard SI, Glover ED, Leischow S, Daughton DM, Glover PN, Muramoto M, Franzon M, Danielsson T, Landfeldt B, Westin A. Rennard SI, et al. Among authors: daughton dm. Nicotine Tob Res. 2006 Aug;8(4):555-64. doi: 10.1080/14622200600789916. Nicotine Tob Res. 2006. PMID: 16920653 Clinical Trial.

2

Evaluation of subclinical respiratory tract inflammation in heavy smokers who switch to a cigarette-like nicotine delivery device that primarily heats tobacco.

Rennard SI, Umino T, Millatmal T, Daughton DM, Manouilova LS, Ullrich FA, Patil KD, Romberger DJ, Floreani AA, Anderson JR. Rennard SI, et al. Among authors: daughton dm. Nicotine Tob Res. 2002 Nov;4(4):467-76. doi: 10.1080/1462220021000018407. Nicotine Tob Res. 2002. PMID: 12521406

3

Smoking cessation.

Rennard SI, Daughton DM. Rennard SI, et al. Among authors: daughton dm. Clin Chest Med. 2014 Mar;35(1):165-76. doi: 10.1016/j.ccm.2013.11.002. Clin Chest Med. 2014. PMID: 24507844 Review.

4

Smoking cessation.

Rennard SI, Daughton DM. Rennard SI, et al. Among authors: daughton dm. Chest. 2000 May;117(5 Suppl 2):360S-4S. doi: 10.1378/chest.117.5_suppl_2.360s. Chest. 2000. PMID: 10843977 Review.

5

Smoking reduction: an alternative approach for smokers who cannot quit.

Millatmal T, Daughton D, Thompson AB, Floreani AA, Romberger D, Epperson K, Larson L, Rennard SI. Millatmal T, et al. Monaldi Arch Chest Dis. 1994 Dec;49(5):421-4. Monaldi Arch Chest Dis. 1994. PMID: 7841980 Review.

6

Transdermal nicotine therapy and primary care. Importance of counseling, demographic, and participant selection factors on 1-year quit rates. The Nebraska Primary Practice Smoking Cessation Trial Group.

Daughton D, Susman J, Sitorius M, Belenky S, Millatmal T, Nowak R, Patil K, Rennard SI. Daughton D, et al. Arch Fam Med. 1998 Sep-Oct;7(5):425-30. doi: 10.1001/archfami.7.5.425. Arch Fam Med. 1998. PMID: 9755734 Clinical Trial.

7

The tobacco withdrawal syndrome: recognition of the physiological rebound phenomenon and treatment implications.

Daughton DM, Rennard SI. Daughton DM, et al. Monaldi Arch Chest Dis. 1993 Oct;48(5):574-5. Monaldi Arch Chest Dis. 1993. PMID: 8312930 No abstract available.

8

Smoking reduction and biological markers of response.

Rennard SI, Daughton DM. Rennard SI, et al. Among authors: daughton dm. Monaldi Arch Chest Dis. 1993 Oct;48(5):580-2. Monaldi Arch Chest Dis. 1993. PMID: 8312932 No abstract available.

9

The smoking cessation efficacy of varying doses of nicotine patch delivery systems 4 to 5 years post-quit day.

Daughton DM, Fortmann SP, Glover ED, Hatsukami DK, Heatley SA, Lichtenstein E, Repsher L, Millatmal T, Killen JD, Nowak RT, Ullrich F, Patil KD, Rennard SI. Daughton DM, et al. Prev Med. 1999 Feb;28(2):113-8. doi: 10.1006/pmed.1998.0391. Prev Med. 1999. PMID: 10048102 Clinical Trial.

10

Effect of transdermal nicotine delivery as an adjunct to low-intervention smoking cessation therapy. A randomized, placebo-controlled, double-blind study.

Daughton DM, Heatley SA, Prendergast JJ, Causey D, Knowles M, Rolf CN, Cheney RA, Hatlelid K, Thompson AB, Rennard SI. Daughton DM, et al. Arch Intern Med. 1991 Apr;151(4):749-52. Arch Intern Med. 1991. PMID: 2012458 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

44 results

Search Page